Arrowhead Pharma Reports Executive & Director Changes
Ticker: ARWR · Form: 8-K · Filed: Apr 15, 2025 · CIK: 879407
Sentiment: neutral
Topics: management-change, personnel
Related Tickers: ARWR
TL;DR
Arrowhead Pharma shuffled execs and directors on 4/11, expect strategic shifts.
AI Summary
On April 11, 2025, Arrowhead Pharmaceuticals, Inc. reported changes in its executive and director positions. The company announced the departure of certain officers and directors, alongside the election of new directors and the appointment of new officers. Specific details regarding compensatory arrangements for certain officers were also disclosed in this filing.
Why It Matters
Changes in key leadership roles can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive and director positions can introduce uncertainty regarding future strategy and leadership stability.
Key Numbers
- 001-38042 — SEC File Number (Identifies the company's filing with the SEC.)
- 46-0408024 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Arrowhead Pharmaceuticals, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 11, 2025 (date) — Date of earliest event reported
- 177 E. Colorado Blvd , Suite 700 , Pasadena , CA 91105 (address) — Principal executive offices
FAQ
Who are the specific officers and directors departing from Arrowhead Pharmaceuticals, Inc.?
The filing indicates the departure of certain officers and directors, but does not name them specifically in the provided text.
Who are the newly elected directors and appointed officers?
The filing states that new directors have been elected and new officers appointed, but their names are not detailed in the provided text.
What is the nature of the compensatory arrangements being disclosed?
The filing mentions compensatory arrangements of certain officers, but the specific details of these arrangements are not provided in the excerpt.
What is the effective date of these reported changes?
The date of the earliest event reported is April 11, 2025.
Where are Arrowhead Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 177 E. Colorado Blvd, Suite 700, Pasadena, CA 91105.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding ARROWHEAD PHARMACEUTICALS, INC. (ARWR).